<div>My name is Grayson. I am 24 years old. Three years ago, I was diagnosed with stage 4 large cell neuroendocrine carcinoma, a rare and aggressive cancer.
</div>
<div><br />
</div>
<div>Since then, most of my life has been organized around treatment schedules, scan dates, and waiting. I have gone through three different lines of chemotherapy, radiation, and a major surgery called an esophagectomy. Each treatment was chosen because it offered time, or the chance to reach another option.
</div>
<div><br />
</div>
<div>Last year, I became the first person in Canada to receive an immunotherapy called Tarlatamab outside of a clinical trial. For the first time since my diagnosis, my scans improved. I could plan more than a few weeks ahead. That period lasted 18 months, and my experience helped move this drug toward becoming a standard option for others with aggressive cancers.
</div>
<div><br />
</div>
<div>The cancer has now progressed, and Tarlatamab is no longer working for me. There are no additional targeted therapies or clinical trials in Canada that match my molecular profile. Under current guidelines, returning to older chemotherapy treatments is not supported. This leaves me with no viable options here.
</div>
<div><br />
</div>
<div>Because of this, my family and I are seeking care in the United States. I have been accepted into a clinical trial at Hackensack University Medical Center in New Jersey. This trial is the only remaining treatment option available to me.
</div>
<div><br />
</div>
<div>The trial drug itself is covered, but everything required to access it is not. Initial visits occur weekly for the first few months and then every three weeks. We are responsible for flights, accommodations, drug administration, bloodwork, CT and MRI scans, and physician visits. Unfortunately, there is not government funding to support this. If we cannot cover these costs, I cannot stay in the trial.
</div>
<div><br />
</div>
<div>I want to spend my time and energy on treatment and recovery, not on whether I will be able to keep showing up.
</div>
<div><br />
</div>
<div>If you are able to donate, share, or support in any way, it would mean more to me than I can put into words. Every contribution helps relieve the stress on my family and allows me to keep doing what I’ve been doing for three years now; fighting with everything I have.
</div>
<div><br />
</div>
<div>Thank you for believing in me.
</div>
<div><br />
</div>
<div>— Grayson
</div>
<div><br />
</div>

Danielle Noreau-Heisz

Adam Whytock

Anonymous

Levi Kassel

Jack Neuberger

Adam Pencer

Genevieve Roy

Alexandre Iolov

Nathalie Dore

Anne D

Saurabh Popat

Arron Shaddock

Richard Marchello

Support Grayson's Battle Against Cancer

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

Native 11.4.0 and higher

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Support Grayson's Battle Against Cancer

Still $54,950 to go. Help us build momentum.